Bradycardic syncope in 2 patients who recently began gatifloxacin treatment.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12539087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999. Few side effects of this new antibiotic have been reported, and there are no previous case reports of bradyarrhythmias. We report 2 cases of syncope due to bradycardia in patients who recently began treatment with gatifloxacin.
Medical subject headings
- Anti-Infective Agents
- Bradycardia
- Fluoroquinolones
- Syncope